{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:24:24Z","timestamp":1774441464907,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04672-3","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:56:54Z","timestamp":1770299814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of broad-host-range bacteriophages targeting multidrug-resistant E. coli and Shigella spp.: in vitro potential"],"prefix":"10.1186","volume":"26","author":[{"given":"Nicola","family":"Mangieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaidra","family":"Gaufin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Ghatbale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Picozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"4672_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1313","author":"J Pizzato","year":"2022","unstructured":"Pizzato J, Tang W, Bernabeu S, Bonnin RA, Bille E, Farfour E, et al. Discrimination of Escherichia coli, Shigella flexneri, and Shigella sonnei using lipid profiling by MALDI-TOF mass spectrometry paired with machine learning. Microbiol Open. 2022. https:\/\/doi.org\/10.1002\/mbo3.1313.","journal-title":"Microbiol Open"},{"key":"4672_CR2","unstructured":"Beld MJCvanden, Rossen JWA, Evers A, Kooistra-Smid AMDM, Reubsaet FAG. Matrix-assisted laser desorption-ionization time-of-flight mass spectrometry using a custom-made database, biomarker assignment or mathematical classifiers does not differentiate Shigella spp. and Escherichia coli. bioRxiv. 2019."},{"key":"4672_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00906-1","author":"S Baker","year":"2023","unstructured":"Baker S, Scott TA. Antimicrobial-resistant shigella: where do we go next? Nat Rev Microbiol. 2023. https:\/\/doi.org\/10.1038\/s41579-023-00906-1.","journal-title":"Nat Rev Microbiol"},{"key":"4672_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00370-X","author":"H Charles","year":"2022","unstructured":"Charles H, Prochazka M, Thorley K, Crewdson A, Greig DR, Jenkins C, et al. Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021\u201322: a descriptive epidemiological study. Lancet Infect Dis. 2022. https:\/\/doi.org\/10.1016\/S1473-3099(22)00370-X.","journal-title":"Lancet Infect Dis"},{"key":"4672_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123\u201340. https:\/\/doi.org\/10.1038\/nrmicro818.","journal-title":"Nat Rev Microbiol"},{"key":"4672_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.09.009","author":"AP Dale","year":"2015","unstructured":"Dale AP, Woodford N. Extra-intestinal pathogenic Escherichia coli (ExPEC): disease, carriage and clones. J Infect. 2015. https:\/\/doi.org\/10.1016\/j.jinf.2015.09.009.","journal-title":"J Infect"},{"key":"4672_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/10408398.2011.625574","volume":"54","author":"S Micali","year":"2014","unstructured":"Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M. Cranberry and recurrent cystitis: more than marketing? Crit Rev Food Sci Nutr. 2014;54:1063\u201375. https:\/\/doi.org\/10.1080\/10408398.2011.625574.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4672_CR8","doi-asserted-by":"publisher","unstructured":"Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: Virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol 2017;8 AUG. https:\/\/doi.org\/10.3389\/fmicb.2017.01566","DOI":"10.3389\/fmicb.2017.01566"},{"key":"4672_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"key":"4672_CR10","doi-asserted-by":"publisher","unstructured":"Foxman B. Urinary tract infection syndromes. Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin N Am. 2014;28. https:\/\/doi.org\/10.1016\/j.idc.2013.09.003.","DOI":"10.1016\/j.idc.2013.09.003"},{"key":"4672_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00397-06","author":"J Xie","year":"2006","unstructured":"Xie J, Foxman B, Zhang L, Marrs CF. Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder. J Clin Microbiol. 2006. https:\/\/doi.org\/10.1128\/JCM.00397-06.","journal-title":"J Clin Microbiol"},{"key":"4672_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06435-7","author":"GK Bunduki","year":"2021","unstructured":"Bunduki GK, Heinz E, Phiri VS, Noah P, Feasey N, Musaya J. Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-06435-7.","journal-title":"BMC Infect Dis"},{"key":"4672_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33296-8","author":"KL Kotloff","year":"2018","unstructured":"Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2018. https:\/\/doi.org\/10.1016\/S0140-6736(17)33296-8.","journal-title":"Lancet"},{"key":"4672_CR14","doi-asserted-by":"publisher","DOI":"10.3201\/eid2806.220131","author":"T Gaufin","year":"2022","unstructured":"Gaufin T, Blumenthal J, Ramirez-Sanchez C, Mehta S, Pride DT, Fierer J, et al. Antimicrobial-resistant Shigella spp. in San Diego, California, USA, 2017\u20132020. Emerg Infect Dis. 2022. https:\/\/doi.org\/10.3201\/eid2806.220131.","journal-title":"Emerg Infect Dis"},{"key":"4672_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8:162. https:\/\/doi.org\/10.4292\/wjgpt.v8.i3.162.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"4672_CR16","doi-asserted-by":"publisher","unstructured":"Sybesma W, Zbinden R, Chanishvili N, Kutateladze M, Chkhotua A, Ujmajuridze A, et al. Bacteriophages as potential treatment for urinary tract infections. Front Microbiol. 2016. https:\/\/doi.org\/10.3389\/fmicb.2016.00465.","DOI":"10.3389\/fmicb.2016.00465"},{"key":"4672_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-019-09629-x","author":"AH Azam","year":"2019","unstructured":"Azam AH, Tanji Y. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Appl Microbiol Biotechnol. 2019. https:\/\/doi.org\/10.1007\/s00253-019-09629-x.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"4672_CR18","first-page":"20","volume":"41","author":"L Bren","year":"2007","unstructured":"Bren L. Bacteria-eating virus approved as food additive. FDA Consum. 2007;41(1):20\u20132.","journal-title":"FDA Consum"},{"key":"4672_CR19","unstructured":"European Medicines Agency Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections, 19 May 2022, CPMP\/EWP\/558\/95 Rev 3."},{"key":"4672_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111423","author":"N Mangieri","year":"2021","unstructured":"Mangieri N, Foschino R, Picozzi C. Application of bacteriophages on Shiga toxin-producing Escherichia coli (STEC) biofilm. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10111423.","journal-title":"Antibiotics"},{"key":"4672_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01801","author":"N Mangieri","year":"2020","unstructured":"Mangieri N, Picozzi C, Cocuzzi R, Foschino R. Evaluation of a potential bacteriophage cocktail for the control of Shiga-toxin producing Escherichia coli in food. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.01801.","journal-title":"Front Microbiol"},{"key":"4672_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2007.09.004","author":"T Freitag","year":"2008","unstructured":"Freitag T, Squires RA, Schmid J. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro. Res Vet Sci. 2008. https:\/\/doi.org\/10.1016\/j.rvsc.2007.09.004.","journal-title":"Res Vet Sci"},{"key":"4672_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00574","author":"P Manohar","year":"2019","unstructured":"Manohar P, Tamhankar AJ, Lundborg CS, Nachimuthu R. Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, klebsiella pneumoniae, and enterobacter species. Front Microbiol. 2019. https:\/\/doi.org\/10.3389\/fmicb.2019.00574.","journal-title":"Front Microbiol"},{"key":"4672_CR24","doi-asserted-by":"publisher","unstructured":"Miot HA. Correlation analysis in clinical and experimental studies. Jornal Vascular Brasileiro. 2018;17. https:\/\/doi.org\/10.1590\/1677-5449.174118.","DOI":"10.1590\/1677-5449.174118"},{"key":"4672_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68389-1","author":"O Hylling","year":"2020","unstructured":"Hylling O, Carstens AB, Kot W, Hansen M, Neve H, Franz CMAP, et al. Two novel bacteriophage genera from a groundwater reservoir highlight subsurface environments as underexplored biotopes in bacteriophage ecology. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-68389-1.","journal-title":"Sci Rep"},{"key":"4672_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-1027","author":"A Lopes","year":"2014","unstructured":"Lopes A, Tavares P, Petit MA, Gu\u00e9rois R, Zinn-Justin S. Automated classification of tailed bacteriophages according to their neck organization. BMC Genomics. 2014. https:\/\/doi.org\/10.1186\/1471-2164-15-1027.","journal-title":"BMC Genomics"},{"key":"4672_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-022-05694-2","author":"D Turner","year":"2023","unstructured":"Turner D, Shkoporov AN, Lood C, Millard AD, Dutilh BE, Alfenas-Zerbini P, et al. Abolishment of morphology-based taxa and change to binomial species names: 2022 taxonomy update of the ICTV bacterial viruses subcommittee. Arch Virol. 2023. https:\/\/doi.org\/10.1007\/s00705-022-05694-2.","journal-title":"Arch Virol"},{"key":"4672_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01480-09","author":"KP Williams","year":"2010","unstructured":"Williams KP, Gillespie JJ, Sobral BWS, Nordberg EK, Snyder EE, Shallom JM, et al. Phylogeny of gammaproteobacteria. J Bacteriol. 2010. https:\/\/doi.org\/10.1128\/JB.01480-09.","journal-title":"J Bacteriol"},{"key":"4672_CR29","doi-asserted-by":"publisher","unstructured":"Le\u00e3o I, de Carvalho TB, Henriques V, Ferreira C, Sampaio-Maia B, Manaia CM. Pseudomonadota in the oral cavity: a glimpse into the environment-human nexus. Appl Microbiol Biotechnol 2023;107. https:\/\/doi.org\/10.1007\/s00253-022-12333-y","DOI":"10.1007\/s00253-022-12333-y"},{"key":"4672_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx157","author":"Y Nishimura","year":"2017","unstructured":"Nishimura Y, Yoshida T, Kuronishi M, Uehara H, Ogata H, Goto S. ViPTree: the viral proteomic tree server. Bioinformatics. 2017. https:\/\/doi.org\/10.1093\/bioinformatics\/btx157.","journal-title":"Bioinformatics"},{"key":"4672_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000799","author":"AM Comeau","year":"2007","unstructured":"Comeau AM, T\u00e9tart F, Trojet SN, Pr\u00e8re MF, Krisch HM. Phage-antibiotic synergy (PAS): \u03b2-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One. 2007. https:\/\/doi.org\/10.1371\/journal.pone.0000799.","journal-title":"PLoS One"},{"key":"4672_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0169-z","author":"C Torres-Barcel\u00f3","year":"2018","unstructured":"Torres-Barcel\u00f3 C. The disparate effects of bacteriophages on antibiotic-resistant bacteria. Emerg Microbes Infect. 2018. https:\/\/doi.org\/10.1038\/s41426-018-0169-z.","journal-title":"Emerg Microbes Infect"},{"key":"4672_CR33","doi-asserted-by":"publisher","unstructured":"Galtier M, De Sordi L, Maura D, Arachchi H, Volant S, Dillies MA, et al. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environ Microbiol. 2016;18. https:\/\/doi.org\/10.1111\/1462-2920.13284","DOI":"10.1111\/1462-2920.13284"},{"key":"4672_CR34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i30.5486","author":"MC Cenit","year":"2017","unstructured":"Cenit MC, Sanz Y, Codo\u00f1er-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol. 2017. https:\/\/doi.org\/10.3748\/wjg.v23.i30.5486.","journal-title":"World J Gastroenterol"},{"key":"4672_CR35","doi-asserted-by":"publisher","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s Dis. Cell. 2016;167. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"4672_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002203","author":"A Llanos-Chea","year":"2019","unstructured":"Llanos-Chea A, Citorik RJ, Nickerson KP, Ingano L, Serena G, Senger S, et al. Bacteriophage therapy testing against Shigella flexneri in a novel human intestinal organoid-derived infection model. J Pediatr Gastroenterol Nutr. 2019. https:\/\/doi.org\/10.1097\/MPG.0000000000002203.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4672_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.09.015","author":"H Br\u00fcssow","year":"2012","unstructured":"Br\u00fcssow H. What is needed for phage therapy to become a reality in Western medicine? Virology. 2012. https:\/\/doi.org\/10.1016\/j.virol.2012.09.015.","journal-title":"Virology"},{"key":"4672_CR38","unstructured":"ANSES (French Agency for Food, Environmental and Occupational Health & Safety), 2014. Opinion of ANSES on the use of bacteriophages in foods of animal origin to control Listeria. pp. 27. Available online: https:\/\/www.anses.fr\/en\/system\/files\/BIORISK2013sa0111.pdf."},{"key":"4672_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01674","author":"V Hietala","year":"2019","unstructured":"Hietala V, Horsma-Heikkinen J, Carron A, Skurnik M, Kiljunen S. The removal of endo- and enterotoxins from bacteriophage preparations. Front Microbiol. 2019. https:\/\/doi.org\/10.3389\/fmicb.2019.01674.","journal-title":"Front Microbiol"},{"key":"4672_CR40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/mbo3.384","volume":"5","author":"A Washizaki","year":"2016","unstructured":"Washizaki A, Yonesaki T, Otsuka Y. Characterization of the interactions between Escherichia coli receptors, LPS and OmpC, and bacteriophage T4 long tail fibers. MicrobiologyOpen. 2016;5:1003\u201315. https:\/\/doi.org\/10.1002\/mbo3.384.","journal-title":"MicrobiologyOpen"},{"key":"4672_CR41","doi-asserted-by":"publisher","unstructured":"Ruest MK, Supina BSI, Dennis JJ. Bacteriophage steering of Burkholderia cenocepacia toward reduced virulence and increased antibiotic sensitivity. J Bacteriol. 2023;205. https:\/\/doi.org\/10.1128\/jb.00196-23","DOI":"10.1128\/jb.00196-23"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04672-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:28:52Z","timestamp":1774430932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04672-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04672-3","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subject involvement in this study was approved by the University of California, San Diego Administrative Panel on Human Subjects in Medical Research (protocol#160524). The study was approved as category 4 exempt, which includes research involving the collection or study of existing data, documents, records, or diagnostic specimens, if the information is recorded in such a manner that human subjects cannot be identified, directly or through identifiers linked to the subjects. Under this IRB (Institutional Review Board) exemption protocol, there is no direct contact with human subjects, no subject identifiers used in the research, and the informed consent process is waived. This study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}